The Latest Breaking News from JJ.

J&J reached an $8.9 billion settlement in ongoing litigation over its talc-based baby powders, leading JNJ stock to rise Wednesday.

Former president appeared subdued in New York, only to return to his inflammatory ways in Florida. Plus, the campaigners using using dating apps to boost voter turnout

Johnson & Johnson ducked out of the RSV vaccine race Wednesday, leaving Pfizer, GSK and Moderna to duke it out.

Covid vaccines took a major toll on Johnson & Johnson and Danaher early Tuesday, hitting J&J's fourth-quarter sales and Danaher's guidance.

Anna Sutton was shocked when she received a letter from her husband’s job-based health plan stating that Humira, an expensive drug used to treat her daughter’s juvenile arthritis, was now on a long list of medications considered “nonessential benefits.”

Johnson & Johnson topped third-quarter expectations on Thursday despite exchange-rate challenges, but JNJ stock pared back gains.

BeiGene stock catapulted Wednesday after the company's leukemia treatment beat out a blockbuster drug from Johnson & Johnson.

CHICAGO — As the 40th anniversary of the 1982 Tylenol murders approaches, investigators are working with prosecutors on a now-or-maybe-never effort to hold a longtime suspect responsible for the poisonings that killed seven people in the Chicago area, the Tribune has learned.

Critics say a legal maneuver by one of the world's wealthiest corporations could set a precedent, allowing non-bankrupt companies and rich individuals to avoid liability for wrongdoing.